Knilonat 200® Nilotinib Capsules

Knilonat 200 mg contains nilotinib, a targeted anticancer medicine used to treat Philadelphia chromosome-positive chronic myeloid leukaemia (CML), a type of blood cancer. It blocks the abnormal BCR-ABL protein responsible for uncontrolled growth of certain white blood cells.

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.